BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 7487260)

  • 1. Gender differences in device therapy for malignant ventricular arrhythmias.
    Horton HL; Marinchak RA; Rials SJ; Kowey PR
    Arch Intern Med; 1995 Nov; 155(21):2342-5. PubMed ID: 7487260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial.
    Russo AM; Stamato NJ; Lehmann MH; Hafley GE; Lee KL; Pieper K; Buxton AE;
    J Cardiovasc Electrophysiol; 2004 Sep; 15(9):993-8. PubMed ID: 15363069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction.
    Zareba W; Moss AJ; Jackson Hall W; Wilber DJ; Ruskin JN; McNitt S; Brown M; Wang H;
    J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1265-70. PubMed ID: 16403053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators.
    Chen HA; Hsia HH; Vagelos R; Fowler M; Wang P; Al-Ahmad A
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):390-4. PubMed ID: 17367359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery.
    O'Neill JO; Starling RC; Khaykin Y; McCarthy PM; Young JB; Hail M; Albert NM; Smedira N; Chung MK
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1250-6. PubMed ID: 16256775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable cardioverter-defibrillator: present and future indications.
    Block M; Scheld H; Breithardt G
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators.
    Lampert R; McPherson CA; Clancy JF; Caulin-Glaser TL; Rosenfeld LE; Batsford WP
    J Am Coll Cardiol; 2004 Jun; 43(12):2293-9. PubMed ID: 15193696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An "aggressive" protocol of programmed ventricular stimulation for selecting post-myocardial infarction patients with a low ejection fraction who may not require implantation of an automatic defibrillator.
    Belhassen B; Ohayon-Tsioni T; Glick A; Viskin S
    Isr Med Assoc J; 2009 Sep; 11(9):520-4, 526, 528. PubMed ID: 19960844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.
    Moss AJ; Hall WJ; Cannom DS; Daubert JP; Higgins SL; Klein H; Levine JH; Saksena S; Waldo AL; Wilber D; Brown MW; Heo M
    N Engl J Med; 1996 Dec; 335(26):1933-40. PubMed ID: 8960472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical decisions in the management of sudden cardiac death and malignant ventricular arrhythmias. Subendocardial resection, the automatic internal defibrillator, or both.
    Hargrove WC; Josephson ME; Marchlinski FE; Miller JM
    J Thorac Cardiovasc Surg; 1989 Jun; 97(6):923-8. PubMed ID: 2724998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myocardial revascularization in malignant ventricular tachyarrhythmia--prognostic significance].
    Pleskot M; Parízek P; Hodac M; Haman L; St'ásek J; Cervinka P; Tauchman M
    Cas Lek Cesk; 2000 Jan; 139(1):13-7. PubMed ID: 10750286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Short-term and long-term outcome of left heart function after cardioverter defibrillator implantation].
    Takeichi K; Kasanuki H; Ohnishi S; Endoh Y; Hosoda S
    J Cardiol; 1996 Nov; 28(5):277-86. PubMed ID: 8953401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term morbidity and mortality of implantation of automatic implantable cardioverter-defibrillator.
    Gartman DM; Bardy GH; Allen MD; Misbach GA; Ivey TD
    J Thorac Cardiovasc Surg; 1990 Sep; 100(3):353-7; discussion 357-9. PubMed ID: 2104516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy.
    Albert CM; Quigg R; Saba S; Estes NA; Shaechter A; Subacius H; Howard A; Levine J; Kadish A;
    Am Heart J; 2008 Aug; 156(2):367-72. PubMed ID: 18657670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality reduction by implantable cardioverter-defibrillators in high-risk patients with heart failure, ischemic heart disease, and new-onset ventricular arrhythmia: an effectiveness study.
    Chan PS; Hayward RA
    J Am Coll Cardiol; 2005 May; 45(9):1474-81. PubMed ID: 15862422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Zaman S; Sivagangabalan G; Narayan A; Thiagalingam A; Ross DL; Kovoor P
    Circulation; 2009 Jul; 120(3):194-200. PubMed ID: 19581496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of implantable cardioverter defibrillators for primary prevention in the community: do women and men equally meet trial enrollment criteria?
    Daugherty SL; Peterson PN; Wang Y; Curtis JP; Heidenreich PA; Lindenfeld J; Vidaillet HJ; Masoudi FA;
    Am Heart J; 2009 Aug; 158(2):224-9. PubMed ID: 19619698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with transvenous implantable cardioverter-defibrillators for treatment of malignant ventricular arrhythmias.
    Jadonath RL; Pogo GJ; Goldner BG; Kalenderian D; Merkatz K; Cohen MB; Snow JS; Cohen TJ
    J Invasive Cardiol; 1995 Apr; 7(3):72-9. PubMed ID: 10155366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocautery-induced ventricular tachycardia and fibrillation during device implantation and explantation.
    Lo R; Mitrache A; Quan W; Cohen TJ
    J Invasive Cardiol; 2007 Jan; 19(1):12-5. PubMed ID: 17297178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.